Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Talaris Therapeutics Inc.

    NASDAQ: TALS · Real-Time Price · USD
    2.72
    -0.02 (-0.73%)
    At close: Oct 19, 2023, 10:00 PM

    Talaris Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -73.21M -73.89M -47.83M
    Depreciation & Amortization
    		 39K 2.16M 623K
    Stock-Based Compensation
    		 6.59M 11.16M 3.78M
    Other Working Capital
    		 n/a -567K 992K
    Other Non-Cash Items
    		 -10.69M -1.38M 735K
    Deferred Income Tax
    		 n/a n/a 394K
    Change in Working Capital
    		 n/a 1.1M 2.31M
    Operating Cash Flow
    		 -77.26M -60.86M -39.99M
    Capital Expenditures
    		 -9K -3.04M -2.44M
    Cash Acquisitions
    		 n/a -58.71K 93.95K
    Purchase of Investments
    		 -366.14M -191.58M -275.88M
    Sales Maturities Of Investments
    		 171.84M 250.29M 181.93M
    Other Investing Acitivies
    		 n/a 58.71K -93.95K
    Investing Cash Flow
    		 -194.31M 55.67M -96.39M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 161.35M 242K 137.4M
    Financial Cash Flow
    		 161.35M 242.00 137.4K
    Net Cash Flow
    		 -110.22M -4.94M 1.02M
    Free Cash Flow
    		 -77.27M -63.9M -42.42M

    Add to Watchlist